Steel Grove Capital Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-23,650
Closed -$80K 350
2018
Q3
$80K Hold
23,650
0.01% 307
2018
Q2
$89K Hold
23,650
0.01% 303
2018
Q1
$97K Hold
23,650
0.02% 299
2017
Q4
$110K Hold
23,650
0.02% 292
2017
Q3
$168K Hold
23,650
0.03% 273
2017
Q2
$171K Hold
23,650
0.03% 262
2017
Q1
$146K Sell
23,650
-1,850
-7% -$11.4K 0.03% 265
2016
Q4
$149K Hold
25,500
0.03% 242
2016
Q3
$135K Buy
+25,500
New +$135K 0.03% 192